首页 > 技术支持 > 文献速递

Reprogrammed NK immune cells target cancer and autoimmune disorders

Nature Biotechnology

MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis. Targeted lipid nanoparticles deliver mRNA to NK cells inside the body.

Related products

Catalog No. Product Name Description Target
HS739226 Anti-Human TIGIT Reference Antibody (SEA-TGT Anti-Human TIGIT Reference Antibody (SEA-TGT, RUO) (HS739226) is a human monoclonal antibody detecting TIGIT. T-cell immunoreceptor with Ig and ITIM domains, TIGIT, V-set and immunoglobulin domain-containing protein 9, V-set and transmembrane domain-containing protein 3, VSIG9, VSTM3